WallStreetZenWallStreetZen

NASDAQ: IMUX
Immunic Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immunic earnings were -$97.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest IMUX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$19.3M, down 24.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IMUX reported annual earnings of -$97.2M, with -3.3% growth. The next IMUX earnings date is May 7, 2026.

IMUX earnings history

Current Revenue
$0.0
Current Earnings
-$97.2M
Current Profit Margin
0%

IMUX Return on Equity

Current Company
-1,197.8%
Current Industry
-31.4%
Current Market
28.9%
IMUX's Return on Equity (-1,197.8%)... subscribe to Premium to read more.
High Return on Equity Performance

IMUX Return on Assets

Current Company
-265%
Current Industry
-9.6%
IMUX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMUX announces earnings.

IMUX Return on Capital Employed

Current Company
1,479.93%
Current Industry
-3.7%
IMUX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMUX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMUX-$96.51M-$97.17MN/A-$0.62
CNTBN/AN/AN/AN/A
CDXS-$30.82M-$43.97MN/A-$0.50
MOLN-$69.82M-$79.04MN/A-$2.12
MIST-$59.11M-$63.06MN/A-$0.75
View Top Biotech Stocks

IMUX earnings dates

Next earnings date
May 7, 2026

Immunic Earnings Reports & History FAQ

What were Immunic's earnings last quarter?

On IMUX's earnings call on Invalid Date, Immunic (NASDAQ: IMUX) reported Q4 2025 earnings per share (EPS) of -$0.07, up 90.79% year over year. Total IMUX earnings for the quarter were -$19.30 million. In the same quarter last year, Immunic's earnings per share (EPS) was -$0.76.

If you're new to stock investing, here's how to buy Immunic stock.

When does Immunic report earnings?

The next IMUX earnings call is Invalid Date. Add IMUX to your watchlist to be reminded of Immunic's next earnings date.

Is Immunic profitable or losing money?

As of the last Immunic earnings report, Immunic is currently losing money. Immunic's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$97.17 million, a 3.32% decrease year over year.

What was IMUX's earnings growth in the past year?

As of Immunic's earnings date in Invalid Date, Immunic's earnings has grown year over year. IMUX earnings in the past year totalled -$97.17 million.

What are Immunic's earnings expectations?

The current EPS estimate for Immunic's earnings report in Invalid Date is -$0.10.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.